Drug information for BANAN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
FOR SUSPENSION; ORAL
EQ 100MG BASE/5ML
Discontinued
CEFPODOXIME PROXETIL
cefpodoxime proxetil
SANKYO
50688
2000-02-10 Label
2000-02-10 Label
2000-02-10 Label
2000-02-10 Label
2000-02-10 Letter
2000-02-10 Label
2000-02-10 Review
2000-02-10 Letter
2000-02-10 Label
2000-02-10 Review
2000-02-10 Letter
2000-02-10 Label
2000-02-10 Review
2000-02-10 Review
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Review
2000-02-10 Review
2000-02-10 Review
FOR SUSPENSION; ORAL
EQ 50MG BASE/5ML
Discontinued
CEFPODOXIME PROXETIL
cefpodoxime proxetil
SANKYO
"
TABLET; ORAL
EQ 100MG BASE
Discontinued
CEFPODOXIME PROXETIL
cefpodoxime proxetil
SANKYO
50687
2000-02-10 Label
2000-02-10 Label
2000-02-10 Label
2000-02-10 Review
2000-02-10 Label
2000-02-10 Review
2000-02-10 Label
2000-02-10 Label
2000-02-10 Label
2000-02-10 Review
2000-02-10 Review
2000-02-10 Review
2000-02-10 Review
2000-02-10 Review
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
2000-02-10 Letter
TABLET; ORAL
EQ 200MG BASE
Discontinued
CEFPODOXIME PROXETIL
cefpodoxime proxetil
SANKYO
"
Drug Adverse Effects information for BANAN
Role code
Indications
Reaction
# Reports
PS
ANTIPYRESIS
LIVER DISORDER
2
PS
ANTIPYRESIS
TOXIC EPIDERMAL NECROLYSIS
2
PS
HYPERURICAEMIA
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
1
PS
INFECTION PROPHYLAXIS
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
1
PS
INFUSION
LIVER DISORDER
1
PS
INFUSION
TOXIC EPIDERMAL NECROLYSIS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
LIVER DISORDER
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
TOXIC EPIDERMAL NECROLYSIS
2
PS
PYELONEPHRITIS
LIVER DISORDER
2
PS
PYELONEPHRITIS
TOXIC EPIDERMAL NECROLYSIS
2
PS
URINARY TRACT INFECTION
LIVER DISORDER
2
PS
URINARY TRACT INFECTION
TOXIC EPIDERMAL NECROLYSIS
2
SS
ANTIPYRESIS
DIARRHOEA HAEMORRHAGIC
2
SS
ANTIPYRESIS
DISSEMINATED INTRAVASCULAR COAGULATION
2
SS
ANTIPYRESIS
DRUG INEFFECTIVE
2
SS
ANTIPYRESIS
HISTIOCYTOSIS HAEMATOPHAGIC
2
SS
ANTIPYRESIS
LIVER DISORDER
2
SS
ANTIPYRESIS
SEPSIS
2
SS
ANTIPYRESIS
TOXIC EPIDERMAL NECROLYSIS
2
SS
HYPERTONIC BLADDER
ATRIOVENTRICULAR BLOCK SECOND DEGREE
1
SS
NASOPHARYNGITIS
ATRIOVENTRICULAR BLOCK SECOND DEGREE
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
DIARRHOEA HAEMORRHAGIC
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
DISSEMINATED INTRAVASCULAR COAGULATION
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INEFFECTIVE
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
HISTIOCYTOSIS HAEMATOPHAGIC
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
LIVER DISORDER
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
SEPSIS
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
TOXIC EPIDERMAL NECROLYSIS
2
SS
PYELONEPHRITIS
DIARRHOEA HAEMORRHAGIC
2
SS
PYELONEPHRITIS
DISSEMINATED INTRAVASCULAR COAGULATION
2
SS
PYELONEPHRITIS
DRUG INEFFECTIVE
2
SS
PYELONEPHRITIS
HISTIOCYTOSIS HAEMATOPHAGIC
2
SS
PYELONEPHRITIS
LIVER DISORDER
2
SS
PYELONEPHRITIS
SEPSIS
2
SS
PYELONEPHRITIS
TOXIC EPIDERMAL NECROLYSIS
2
SS
URINARY TRACT INFECTION
DIARRHOEA HAEMORRHAGIC
2
SS
URINARY TRACT INFECTION
DISSEMINATED INTRAVASCULAR COAGULATION
2
SS
URINARY TRACT INFECTION
DRUG INEFFECTIVE
2
SS
URINARY TRACT INFECTION
HISTIOCYTOSIS HAEMATOPHAGIC
2
SS
URINARY TRACT INFECTION
LIVER DISORDER
2
SS
URINARY TRACT INFECTION
SEPSIS
2
SS
URINARY TRACT INFECTION
TOXIC EPIDERMAL NECROLYSIS
2
C
ANTIBIOTIC PROPHYLAXIS
HEPATIC FAILURE
1
C
ANTIBIOTIC PROPHYLAXIS
LEFT VENTRICULAR DYSFUNCTION
1
C
ANTIBIOTIC PROPHYLAXIS
MYOPATHY
1
C
ARRHYTHMIA
DRUG INTERACTION
1
C
ARRHYTHMIA
EMBOLISM
1
C
ARRHYTHMIA
PNEUMONIA
1
C
ARRHYTHMIA
PULMONARY ALVEOLAR HAEMORRHAGE
1
C
ATRIAL FIBRILLATION
DRUG INTERACTION
1
C
ATRIAL FIBRILLATION
EMBOLISM
1
C
ATRIAL FIBRILLATION
PNEUMONIA
1
C
ATRIAL FIBRILLATION
PULMONARY ALVEOLAR HAEMORRHAGE
1
C
COMPUTERISED TOMOGRAM
HEPATIC FAILURE
1
C
COMPUTERISED TOMOGRAM
LEFT VENTRICULAR DYSFUNCTION
1
C
COMPUTERISED TOMOGRAM
MYOPATHY
1
C
DECREASED APPETITE
HEPATIC FAILURE
2
C
DECREASED APPETITE
LEFT VENTRICULAR DYSFUNCTION
2
C
DECREASED APPETITE
MYOPATHY
2
C
DIARRHOEA
C-REACTIVE PROTEIN INCREASED
1
C
DIARRHOEA
DRUG ERUPTION
1
C
DIARRHOEA
HEPATIC FAILURE
3
C
DIARRHOEA
LEFT VENTRICULAR DYSFUNCTION
3
C
DIARRHOEA
MYOPATHY
3
C
DIARRHOEA
PRURITUS
1
C
DIARRHOEA
RASH
1
C
EXCORIATION
HEPATIC FAILURE
1
C
EXCORIATION
LEFT VENTRICULAR DYSFUNCTION
1
C
EXCORIATION
MYOPATHY
1
C
GASTRIC ULCER
HEPATIC FAILURE
5
C
GASTRIC ULCER
LEFT VENTRICULAR DYSFUNCTION
5
C
GASTRIC ULCER
MYOPATHY
5
C
HEPATIC NEOPLASM MALIGNANT
HEPATIC FAILURE
2
C
HEPATIC NEOPLASM MALIGNANT
LEFT VENTRICULAR DYSFUNCTION
2
C
HEPATIC NEOPLASM MALIGNANT
MYOPATHY
2
C
HEPATITIS B
HEPATIC FAILURE
1
C
HEPATITIS B
LEFT VENTRICULAR DYSFUNCTION
1
C
HEPATITIS B
MYOPATHY
1
C
HYPERTENSION
HEPATIC FAILURE
2
C
HYPERTENSION
LEFT VENTRICULAR DYSFUNCTION
2
C
HYPERTENSION
MYOPATHY
2
C
INFECTION PROPHYLAXIS
HEPATIC FAILURE
1
C
INFECTION PROPHYLAXIS
LEFT VENTRICULAR DYSFUNCTION
1
C
INFECTION PROPHYLAXIS
MYOPATHY
1
C
MEDICAL DIET
HEPATIC FAILURE
1
C
MEDICAL DIET
LEFT VENTRICULAR DYSFUNCTION
1
C
MEDICAL DIET
MYOPATHY
1
C
NAUSEA
HEPATIC FAILURE
1
C
NAUSEA
LEFT VENTRICULAR DYSFUNCTION
1
C
NAUSEA
MYOPATHY
1
C
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
HEPATIC FAILURE
4
C
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
LEFT VENTRICULAR DYSFUNCTION
4
C
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
MYOPATHY
4
C
PNEUMONIA
C-REACTIVE PROTEIN INCREASED
1
C
PNEUMONIA
DRUG ERUPTION
1
C
PNEUMONIA
PRURITUS
1
C
PNEUMONIA
RASH
1
C
PROPHYLAXIS
C-REACTIVE PROTEIN INCREASED
1
C
PROPHYLAXIS
DRUG ERUPTION
1
C
PROPHYLAXIS
HEPATIC FAILURE
6
C
PROPHYLAXIS
LEFT VENTRICULAR DYSFUNCTION
6
C
PROPHYLAXIS
MYOPATHY
6
C
PROPHYLAXIS
PRURITUS
1
C
PROPHYLAXIS
RASH
1
C
STATUS EPILEPTICUS
C-REACTIVE PROTEIN INCREASED
1
C
STATUS EPILEPTICUS
DRUG ERUPTION
1
C
STATUS EPILEPTICUS
PRURITUS
1
C
STATUS EPILEPTICUS
RASH
1
C
UPPER RESPIRATORY TRACT INFLAMMATION
C-REACTIVE PROTEIN INCREASED
1
C
UPPER RESPIRATORY TRACT INFLAMMATION
DRUG ERUPTION
1
C
UPPER RESPIRATORY TRACT INFLAMMATION
PRURITUS
1
C
UPPER RESPIRATORY TRACT INFLAMMATION
RASH
1
Ads by Google